Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer
Glenn J. Hanna(Dana-Farber Cancer Institute), Laura E. MacConaill(Brigham and Women's Hospital), Ravindra Uppaluri(Brigham and Women's Hospital), Alec Kacew(Hospital of the University of Pennsylvania), Robert I. Haddad(Georgetown University), Jochen H. Lorch(Northwestern University), Nicole G. Chau(University of British Columbia), Priyanka Shivdasani(Brigham and Women's Hospital)
Cited by 29
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k